Gibson assembly
Conventional medicine
Gibson assembly is a molecular cloning method that allows for the joining of multiple DNA fragments in a single, isothermal reaction. It is named after its creator, Daniel G. Gibson, who is the chief technology officer and co-founder of the synthetic biology company Telesis Bio. The technology is more efficient than manual plasmid genetic recombination methods but remains expensive as it is still under patent.